Clostridium Difficile (C.Diff.) Implementing Strategies for - PowerPoint PPT Presentation

Dec 24, 2022 •379 likes •504 views

Clostridium Difficile (C.Diff.) Implementing Strategies for Improvement TCPS CDI Performance Includes all TCPS Partner Hospitals Topic 2016 2017 Events SIR Hospital Events SIR Hospital Outliers Outliers C.DIFF. 2,169 0.879 9

Clostridium Difficile (C.Diff.) Implementing Strategies for Improvement
TCPS CDI Performance Includes all TCPS Partner Hospitals Topic 2016 2017 Events SIR Hospital Events SIR Hospital Outliers Outliers C.DIFF. 2,169 0.879 9 1,983 0.832 4 Data Source: NHSN as of 6/12/2018 This information is prepared and protected in accordance with the Tennessee Patient Safety and Quality Improvement Act of 2011. T.C.A. 68-11-272.
HRET CDI Sprint Two participating facilities May 22 – July 12, 2018
HRET CDI Sprint • Self-assessment with feedback from HRET • Auditing and RCA tools • Coaching from SHA • Webinars based on facility size for sharing of successful strategies
Lessons Learned Diagnostic Lab Stewardship Stewardship
Lessons Learned Diagnostic Stewardship
Lessons Learned Lab Stewardship

Recommend

Clostridium difficile Infection (CDI) Gail Bennett, RN, MSN, CIC 1 Clostridium difficile

Clostridium difficile Infection (CDI) Gail Bennett, RN, MSN, CIC 1 Clostridium difficile (C.difficile) Antibiotic induced diarrhea Can cause pseudomembranous colitis Most common cause of acute infectious diarrhea in nursing homes

621 views • 50 slides

11/5/2015 Some history first The Epidemiology of Clostridium difficile Clostridium

11/5/2015 Some history first The Epidemiology of Clostridium difficile Clostridium difficile , a spore-forming gram-positive (i.e., thick cell wall) anaerobic bacillus, was initially detected in the fecal flora of healthy newborns in D A

250 views • 3 slides

IMM-529 for the prevention and treatment of Clostridium difficile infections Clostridium

IMM-529 for the prevention and treatment of Clostridium difficile infections Clostridium difficile http://www.nlm.nih.gov/medlineplus/images/clostridiumdifficile.jpg Gram positive, spore forming anaerobe Major nosocomial pathogen

929 views • 45 slides

Impact of C. difficile in Canada What is Clostridium difficile ? Spore-forming bacteria

Antimicrobial Stewardship Backgrounder: Clostridium difficile Infection (CDI) Susan Fryters, BScPharm, ACPR Antimicrobial Utilization/Infectious Diseases Pharmacist Alberta Health Services Susan.Fryters@albertahealthservices.ca Effective, Safe,

308 views • 4 slides

Multidrug-Resistant Organism (MDRO) and Clostridium difficile -Associated Disease (CDAD) Module

Multidrug-Resistant Organism (MDRO) and Clostridium difficile -Associated Disease (CDAD) Module Training Course Section: C. difficile Infection Surveillance and C. difficile LabID Event Reporting 1 C. Difficile Infection Target Audience This

842 views • 52 slides

for Clostridium difficile Janel Liane Cala, RPh Medical Center Hospital Objectives Review

Bezlotoxumab (Zinplava) as Adjunct Treatment for Clostridium difficile Janel Liane Cala, RPh Medical Center Hospital Objectives Review pathophysiology, risk factors, prevention, and treatment options of Clostridium difficile Infection (CDI)

662 views • 31 slides

Disclosures Consultant: Genentech Clostridium difficile infection Sarah Doernberg, MD, MAS

Disclosures Consultant: Genentech Clostridium difficile infection Sarah Doernberg, MD, MAS Associate Professor, Division of Infectious Diseases Medical Director of Adult Antimicrobial Stewardship Some controversy Outline Clostridium versus

518 views • 15 slides

Clostridium difficile infections Contrast diagnostic testing for CDI Describe treatment

Objectives Recognize patients at risk for C. difficile infection (CDI) Clostridium difficile infections Contrast diagnostic testing for CDI Describe treatment strategies for mild, severe, and fulminant CDI and fecal transplant

371 views • 15 slides

Improving risk prediction of Clostridium Difficile Infection using temporal event-pairs Mauricio

Improving risk prediction of Clostridium Difficile Infection using temporal event-pairs Mauricio Monsalve Computational Epidemiology (compepi) group The University of Iowa A A T T A G A G LANCE LANCE Clostridium Difficile Infection (CDI)

290 views • 27 slides

The Epidemiology of Clostridium difficile D A N I E L S A M A N , D R P H , M P H R E S E A

The Epidemiology of Clostridium difficile D A N I E L S A M A N , D R P H , M P H R E S E A R C H S C I E N T I S T E S S E N T I A I N S T I T U T E O F R U R A L H E A L T H Some history first Clostridium difficile , a

419 views • 18 slides

Nosocomial Clostridium difficile Infection (CDI): Things Are Not Always As They Seem Angela

Nosocomial Clostridium difficile Infection (CDI): Things Are Not Always As They Seem Angela Wigmore, K. Suh, N. Bruce, G. Garber, C. Chambers, Liz Van Horne, V. Allen, C. Egan, K. Stockton, V. Roth Disclosure None of the authors on this

382 views • 16 slides

Clostridium difficile infection (CDI) in the Pediatric Population Childrens Hospitals FHA

Clostridium difficile infection (CDI) in the Pediatric Population Childrens Hospitals FHA Hospital Improvement Innovation Network (HIIN) May 1, 2018 Overview Welcome Back Review of the data Interactive Presentation by Linda

1.05k views • 69 slides

Clostridium difficile infection Sarah Doernberg, MD, MAS Associate Professor, Division of

Clostridium difficile infection Sarah Doernberg, MD, MAS Associate Professor, Division of Infectious Diseases Medical Director of Adult Antimicrobial Stewardship Disclosures Consultant: Genentech, Basilea Pharmaceutica 1 | [footer text

542 views • 29 slides

Clostridium difficile Sarah Doernberg, MD, MAS Assistant professor and Medical Director of

Clostridium difficile Sarah Doernberg, MD, MAS Assistant professor and Medical Director of Antimicrobial Stewardship Division of Infectious Diseases, UCSF 2.19,2018 Outline Brief background and epidemiology Diagnosis

618 views • 30 slides

Antibiotic stewardship and Clostridium difficile infection Sarah Doernberg, MD, MAS Associate

Antibiotic stewardship and Clostridium difficile infection Sarah Doernberg, MD, MAS Associate Professor, Division of Infectious Diseases Medical Director of Adult Antimicrobial Stewardship Disclosures Consultant: Genentech, Actelion 1 |

456 views • 45 slides

Kansas HEN 2.0 Collaborative Meeting November 18, 2015 Reducing Clostridium Difficile and Improving

Kansas HEN 2.0 Collaborative Meeting November 18, 2015 Reducing Clostridium Difficile and Improving Antimicrobial Stewardship WHATS THE POOPMMM...SCOOP?! Cheryl Ruble, MS, RN CNS Improvement Advisor, Cynosure Health 1 2014 Silver Award

486 views • 27 slides

With Clostridium Difficile Infections: Observational Data Of The French Survey CLOdi Arnaud

Management Of Elderly Patients With Clostridium Difficile Infections: Observational Data Of The French Survey CLOdi Arnaud CAUPENNE, Gaetan GAVAZZI, Marc PACCALIN University of Poitiers, FRANCE Intergroupe GInGer CONFLICT OF INTEREST

596 views • 13 slides

Clostridium difficile Disclosures: Consultant for Actelion, prior research studies with Cerexa,

Clostridium difficile Disclosures: Consultant for Actelion, prior research studies with Cerexa, Merck, Cubist Sarah Doernberg, MD, MAS Assistant Professor, University of California, San Francisco Medical Director, Adult Antimicrobial

498 views • 15 slides

Epidemiology, Diagnosis, and Prevention of Clostridium difficile Infection Erik R. Dubberke, MD,

Epidemiology, Diagnosis, and Prevention of Clostridium difficile Infection Erik R. Dubberke, MD, MSPH Associate Professor of Medicine Washington University School of Medicine Disclosures Consulting: Merck, Sanofi Pasteur, Rebiotix, Pfizer,

660 views • 38 slides

PHARMACIST DRIVEN PROBIOTIC PROTOCOL FOR THE PREVENTION OF HOSPITAL ONSET CLOSTRIDIUM DIFFICILE

RETROSPECTIVE REVIEW OF THE EFFICACY OF A PHARMACIST DRIVEN PROBIOTIC PROTOCOL FOR THE PREVENTION OF HOSPITAL ONSET CLOSTRIDIUM DIFFICILE INFECTIONS AMONG INPATIENTS RECEIVING HIGH-RISK ANTIMICROBIALS Vivian Nguyen, PGY-1 Pharmacy Resident

434 views • 22 slides

IHI Expedition Reducing Clostridium difficile Infections Session 3: Symptom Recognition,

10/16/2014 July 23, 2014 These presenters have nothing to disclose IHI Expedition Reducing Clostridium difficile Infections Session 3: Symptom Recognition, Precautions, and the Role of the Environment Brian Koll, MD Carolyn Gould, MD Diane

757 views • 34 slides

IHI Expedition Reducing Clostridium difficile Infections Session 4: The Role of Antibiotic

10/16/2014 August 6, 2014 These presenters have nothing to disclose IHI Expedition Reducing Clostridium difficile Infections Session 4: The Role of Antibiotic Stewardship Belinda Ostrowsky, MD, MPH, FSHEA Phillip Chung, PharmD, MS Brian

734 views • 27 slides

WI Re energizing Clostridium difficile Infection(CDI) Webinar January 26, 2016 Presented by

4/1/2016 WI Re energizing Clostridium difficile Infection(CDI) Webinar January 26, 2016 Presented by DeAnn Richards, MetaStar and Jill Hanson, WHA Objectives for Today Wisconsins CDI plan for 2016 Link between CDI and Antimicrobial

451 views • 17 slides

on Clostridium difficile Sarah Doernberg, MD, MAS Assistant professor and Medical Director of

Disclosures Genentech: Consultant Infectious diarrhea with a focus on Clostridium difficile Sarah Doernberg, MD, MAS Assistant professor and Medical Director of Antimicrobial Stewardship Division of Infectious Diseases, UCSF 4.20.16

471 views • 14 slides